MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Surface-Modified Devices and CDRH

Originally Published MDDI January 2005  

Originally Published MDDI January 2005


Phil Triolo

Coated devices that include drugs or biologics are regulated as combination products by more than one of FDA's centers. Those without drugs are regulated exclusively by CDRH. Examples include hydrophilic guidewires and catheters, and orthopedic implants with thermal spray metallic coatings.

Devices with surface chemical modifications are not truly coated, since no layer is physically applied to the device. These devices include surface-hardened orthopedic implants and some plasma-treated devices, including catheters, and are regulated exclusively by CDRH.

Surface modifications can also be used to improve a coating's adhesion to a device. When used as an adhesion promoter, the modified surface is not intended to be the interface with the biological environment. However, there are certain exceptions. If the modified surface extends beyond the coating, or if the coating degrades and exposes the underlying modified surface, the biocompatibility of the modified surface must be acceptable for the device's intended use.

Copyright ©2005 Medical Device & Diagnostic Industry

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.